Subsequent neoplasm risk up for decades in child CA survivors

August 13, 2015
Subsequent neoplasm risk up for decades in child CA survivors

(HealthDay)—Survivors of childhood cancer are at increased risk for treatment-related subsequent neoplasms (SNs), even after age 40 years, according to a study published online Aug. 10 in the Journal of Clinical Oncology.

Lucie M. Turcotte, M.D., M.P.H., from the University of Minnesota Medical School in Minneapolis, and colleagues examined SN incidence beyond the age of 40 years in survivors. Among 14,364 survivors, 3,171 had attained an age of 40 years or older at the time of last contact.

The researchers identified 679 SNs that were diagnosed in patients aged 40 years or older, including 196 subsequent malignant neoplasms (SMNs), 419 , 21 nonmalignant meningiomas, and 43 other benign neoplasms. The cumulative incidence of new SNs and SMNs occurring after age 40 years was 34.6 and 16.3 percent, respectively, at age 55 years. The likelihood of receiving a diagnosis of SMN after age 40 years was increased compared with the general population (standardized incidence ratio [SIR], 2.2; 95 percent confidence interval [CI], 1.9 to 2.5). Among SMNs, risk was increased for breast cancer, renal cancer, , and thyroid cancer (SIRs [95 percent CIs]: 5.5 [4.5 to 6.7], 3.9 [2.0 to 7.5], 2.6 [1.5 to 4.4], and 1.9 [1.0 to 3.5], respectively). In multivariable analysis, female sex and therapeutic radiation exposure correlated with increased risk of SMN (relative risks, 1.9 and 2.2, respectively; both P < 0.001).

"These data suggest the need for life-long monitoring and should inform anticipatory guidance provided to survivors of childhood cancer," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Explore further: Childhood cancer survivors at increased risk of certain tumors in middle-age

More information: Abstract
Full Text (subscription or payment may be required)
Editorial

Related Stories

Childhood cancer survivors at increased risk of certain tumors in middle-age

June 5, 2011
In a study that included nearly 18,000 children who had cancer, with follow-up of about 25 years, the greatest excess risk associated with a subsequent primary neoplasm (a new tumor) at older than age 40 years was for digestive ...

Exercise cuts later CV risk in hodgkin's lymphoma survivors

October 16, 2014
(HealthDay)—Exercise may lower the risk of treatment-related cardiovascular events in adult survivors of childhood Hodgkin's lymphoma, according to research published online Oct. 13 in the Journal of Clinical Oncology.

Chest radiation to treat childhood cancer increases patients' risk of breast cancer

October 27, 2014
A new study has found that patients who received chest radiation for Wilms tumor, a rare childhood cancer, face an increased risk of developing breast cancer later in life due to their radiation exposure. Published early ...

Cancer risk up in bilateral retinoblastoma survivors

February 23, 2012
(HealthDay) -- For survivors of bilateral retinoblastoma (Rb), family history is associated with an increased risk of second cancers (SCs), especially melanoma, according to a study published online Feb. 21 in the Journal ...

Risk of diabetes up in hodgkin's lymphoma survivors

August 27, 2014
(HealthDay)—Para-aortic radiation correlates with increased diabetes mellitus (DM) risk for Hodgkin's lymphoma (HL) survivors, according to a study published online Aug. 25 in the Journal of Clinical Oncology.

Metformin use associated with less CRC risk in US population

April 1, 2015
(HealthDay)—For patients with diabetes in the United States, metformin use is associated with reduced risk of developing colorectal cancer (CRC), according to a study published in the April 1 issue of Cancer.

Recommended for you

Sequencing genomes of Nigerian women could help prevent many lethal breast cancers

August 21, 2018
For the first time, DNA contributed by Sub-Saharan African women has been thoroughly evaluated with innovative genomics technology in an effort to understand the genetic bases for breast cancer in African populations.

First in-depth profile of CAR T-cell signals suggests how to improve immunotherapy

August 21, 2018
CAR T-cell therapy, which reprograms immune cells to fight cancer, has shown great promise in people with some blood cancers who have not responded to other treatments. But until now, the underlying biological pathways enabling ...

Scientists take step toward new, targeted lung cancer treatment

August 21, 2018
Scientists have identified a key molecular player in a subtype of lung cancer which could lead to a new way to tackle the disease, according to research published in Nature Communications.

New compound advances into Phase 1 trial for pancreatic cancer

August 21, 2018
A compound discovered at Sanford Burnham Prebys Medical Discovery Institute (SBP) has advanced into a Phase 1 trial for metastatic pancreatic cancer. Called CEND-1 (scientifically known as iRGD), the compound was exclusively ...

Simple test could identify bladder cancer patients who won't respond to immunotherapy

August 21, 2018
Patients who are unlikely to benefit from a commonly used immunotherapy for bladder cancer could be identified by a simple blood test, according to researchers at Brighton and Sussex Medical School (BSMS).

Annual pap test a 'thing of the past?'

August 21, 2018
The United States Preventive Services Task Force (USPSTF) has released new recommendations on screening for cervical cancer. These latest recommendations continue the trend of decreasing participant burden by lengthening ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.